Symflor

Symflor is a Dutch biotechnology company specializing in the development and commercialization of high-quality probiotic solutions and live biotherapeutic products. The company focuses on the human microbiome, particularly in the areas of infant health, digestive wellness, and immune support. Symflor leverages clinical research to formulate specific microbial strains, such as Lactobacillus rhamnosus GG, to address conditions like infant colic and antibiotic-associated diarrhea. Their business model encompasses both the direct marketing of branded supplements and the provision of microbiome-based solutions for healthcare professional applications. By bridging the gap between nutritional science and clinical medicine, Symflor aims to improve patient outcomes through targeted microbial interventions.